The first is obvious, accelerated approval.
But not many people talk about the second possibility that I believe is more and more likely everyday. This is the idea that Sarepta won't file for accelerated approval and the stock will open down sharply only to COMPLETELY rebound and finish close to unchanged. With so many investors on the sidelines just wishing to see a drop in the price to get in this name don't be surprised to see this last scenerio happen. Actually them not filing would completely shock me so maybe you should be surprised to see that scenerio happen.
Thanks for the compliment (I think), however I'm very long. After reading my post I think I didn't articulate what I was trying to say. I believe the odds that they file are around 97%. If they don't file (only 3% chance), the stock will go down and quickly rebound. That's why I believe that many more investors are coming in right now, because the downside is limited.
As I posted before, this stock will slowly crawled towards the $40 level.
Once news of AA filing or breakthrough designation is announced, the stock
will soared past the $50.00 level because of investors chasing and shorts squeeze